Stock Price Forecast
The 4 analysts offering 12-month price forecasts for Ocugen Inc have a median target of 7.00, with a high estimate of 15.00 and a low estimate of 4.00. The median estimate represents a +153.62% increase from the last price of 2.76.
Similarly, Is Ocugen a buy or sell?
Ocugen has received a consensus rating of Hold. The company’s average rating score is 2.40, and is based on 2 buy ratings, 3 hold ratings, and no sell ratings.
What is the target price for OCGN? Stock Price Targets
| High | $15.00 |
|---|---|
| Median | $7.00 |
| Low | $4.00 |
| Average | $8.25 |
| Current Price | $2.9700 |
Thereof, Why is OCGN stock down?
Ocugen’s OCGN stock declined 3.8% on Tuesday after the FDA placed a clinical hold on a phase II/III immuno-bridging and broadening clinical study on its COVID-19 vaccine, Covaxin.
Why is Ocugen stock so low?
The steep decline came after the company announced that the U.S. Food and Drug Administration (FDA) won’t grant Emergency Use Authorization (EUA) for COVID-19 vaccine Covaxin in children ages two to 18.
Is OCGN a buy right now?
According to the issued ratings of 5 analysts in the last year, the consensus rating for Ocugen stock is Hold based on the current 3 hold ratings and 2 buy ratings for OCGN.
Should I buy Ocugen stock?
Ocugen is a dangerous investment, especially given it is unprofitable, it’s burning through money, and investors have been wary of growth stocks of late. Unless you’re prepared for the risk, you’re better off avoiding Ocugen.
What does it mean when a stock is squeezed?
The term squeeze can be used to describe several situations that involve some sort of market pressure. In finance, the term is used to describe situations wherein short-sellers purchase stock to cover losses or when investors sell long positions to take capital gains off the table.
Is Ocugen a buy Zacks?
How good is it? See rankings and related performance below. The VGM Score are a complementary set of indicators to use alongside the Zacks Rank.
…
Momentum Scorecard. More Info.
| Zacks Rank | Definition | Annualized Return |
|---|---|---|
| 1 | Strong Buy | 24.93% |
| 2 | Buy | 18.44% |
| 3 | Hold | 9.99% |
| 4 | Sell | 5.61% |
Who owns OCGN?
Top 10 Owners of Ocugen Inc
| Stockholder | Stake | Shares owned |
|---|---|---|
| BlackRock Fund Advisors | 5.21% | 11,209,731 |
| The Vanguard Group, Inc. | 4.69% | 10,096,039 |
| Geode Capital Management LLC | 1.52% | 3,274,335 |
| JPMorgan Asset Management (UK) Lt… | 1.49% | 3,197,615 |
Is Ocugen publicly traded?
Yes, Ocugen Inc is a publicly traded company.
Why Ocugen is going up?
Shares of Ocugen Inc. OCGN, +14.63% surged 6.4% in morning trading Thursday, to bounce off a near 11-month low, after the biopharmaceutical company said its partner, Bharat Biotech, reported positive results from a trial of its COVID-19 vaccine candidate.
Is Terra Tech a buy?
Is Terra Tech Corp stock A Buy? Terra Tech Corp holds several positive signals, but we still don’t find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.
What is the most shorted stock right now?
Most Shorted Stocks Right Now
- Nikola Corporation (NASDAQ:NKLA) Number of Hedge Fund Holders: 12. Float Shorted: 30.02% …
- Bed Bath & Beyond Inc. (NASDAQ:BBBY) Number of Hedge Fund Holders: 17. …
- SmileDirectClub, Inc. (NASDAQ:SDC) Number of Hedge Fund Holders: 18. …
- Beyond Meat, Inc. (NASDAQ:BYND) …
- Lemonade, Inc. (NYSE:LMND)
Where is the next short squeeze?
How do you tell if a stock is being shorted?
Search for the stock, click on the Statistics tab, and scroll down to Share Statistics, where you’ll find the key information about shorting, including the number of short shares for the company as well as the short ratio.
What kind of stock is OCGN?
Common Stock (OCGN)
How many shares of Ocugen are there?
Share Statistics
| Avg Vol (3 month) 3 | 13.4M |
|---|---|
| Shares Outstanding 5 | 199.19M |
| Implied Shares Outstanding 6 | N/A |
| Float 8 | 195.14M |
| % Held by Insiders 1 | 2.44% |
How many institutions own Ocugen?
Institutional Ownership and Shareholders
Ocugen Inc (US:OCGN) has 261 institutional owners and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 78,470,634 shares.
Is Vanguard invested in OCGN?
2022-02-10 – Vanguard Group Inc has filed an SC 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 10,605,494 shares of Ocugen Inc (US:OCGN). This represents 5.32 percent ownership of the company.
Is Ocugen a long term stock?
Long-term Ocugen stock forecast 2022-2025
The site predicted that the share price could climb over the next year, to $7.2 by March 2023. Over the longer term, Wallet Investor’s forecasts saw the share price reaching $20.6 by March 2027, though with significant fluctuations along the way.
Who is making Covaxin?
COVAXIN®, India‘s indigenous COVID-19 vaccine by Bharat Biotech is developed in collaboration with the Indian Council of Medical Research (ICMR) – National Institute of Virology (NIV).
Is Ocugen vaccine approved?
Ocugen and Bharat Biotech have been partners since 2020 to develop the vaccine, which has been authorized in India for people ages 12 and up.
Who bought OCGN stock?
Top 10 Owners of Ocugen Inc
| Stockholder | Stake | Shares bought / sold |
|---|---|---|
| BlackRock Fund Advisors | 5.21% | +18,773 |
| The Vanguard Group, Inc. | 4.69% | -245,162 |
| Geode Capital Management LLC | 1.52% | -82,481 |
| JPMorgan Asset Management (UK) Lt… | 1.49% | +3,197,615 |
Join TheMoney.co community and don’t forget to share this post !
